SOPH Stock Analysis: Buy, Sell, or Hold?
SOPH - SOPHiA GENETICS SA Ordinary Shares
$5.68
-0.04 (-0.70%)
▼
5d:
+4.41%
30d:
+9.23%
90d:
+17.11%
BUY
HIGH Confidence
Analysis Updated: Jul 14, 2026 12:00 AM ET
Earnings: Aug 04, 2026
20d
Get Alerted When SOPH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: SOPH shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
✅ BUY SIGNAL: SOPH shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
In-depth Analysis How we analyze
Valuation Analysis: SOPH is currently trading at $5.68, which is considered slightly high relative to its 30-day fair value range of $5.14 to $5.71.
Technical Outlook: Technically, SOPH is in a uptrend. Immediate support is located at $4.95, while resistance sits at $6.30.
Market Sentiment: SOPH has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $8.00 (+39.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SOPH is in a uptrend. Immediate support is located at $4.95, while resistance sits at $6.30.
Market Sentiment: SOPH has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $8.00 (+39.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$5.14 -
$5.71
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
83.3%
All Signals
- BULLISH: Options cheap (IV 0th percentile)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 39.9% below Wall St target ($8.00)
Trading Range Analysis
30-Day Trading Range
$5.14 -
$5.71
Current vs Trading Range
SLIGHTLY HIGH
Expected Move (7 Days)
±$0.62
(10.9%)
Support & Resistance Levels
Support Level
$4.95
Resistance Level
$6.30
Current Trend
Uptrend
Technical data as of
Jul 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-10.21
Wall Street Target
$8.00
(+39.9%)
Revenue Growth (YoY)
22.0%
Profit Margin
-99.7%
Share & Embed Analysis
Last updated: July 14, 2026 4:10 PM ET
Data refreshes hourly during market hours. Next update: 5:10 PM
Data refreshes hourly during market hours. Next update: 5:10 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SOPH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
20
Sells
Net
INSIDERS SELLING
Recent Transactions
Kevin Puylaert
SELL
33 shares
2026-04-20
Manuela Valente
SELL
380 shares
2026-04-20
Philippe Menu
SELL
608 shares
2026-04-20
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$245 | 61 BUY |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$32 | 54 HOLD |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 63 BUY |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 56 HOLD |
|
WAY
Waystar Holding Corp. Co… |
STRONG BUY
13 analysts |
$34 | 60 HOLD |
